FDA Inspection
StemCure, Inc.StemCure, Inc. – FDA Inspection, Nov 7, 2022
Record Details
This FDA Inspection record concerns StemCure, Inc., with an inspection on November 7, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- StemCure, Inc.
- Inspection Date
- November 7, 2022
- Product Type
- Biologics
View Company Profile
ID · ccf25990-523b-4e9f-9f0a-24aab373d8a0
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1187512
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of StemCure, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 3, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for StemCure, Inc.
- FDA Inspection 1052724 - 2018-05-08
- FDA Inspection 953354 - 2015-12-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.